Importantly, ADXS31-164 broke peripheral tolerance and delayed development of HER2+positive breast cancer in rat HER2 transgenic mice that are immunologically tolerant to rat HER2 [37]. The gene discussed is ERBB2; the disease is breast carcinoma.